Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) EBT (2016 - 2025)

Historic EBT for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to -$250245.0.

  • Skinvisible's EBT rose 1451.22% to -$250245.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 153.05%. This contributed to the annual value of -$1.3 million for FY2024, which is 4704.46% up from last year.
  • Latest data reveals that Skinvisible reported EBT of -$250245.0 as of Q3 2025, which was up 1451.22% from -$278957.0 recorded in Q2 2025.
  • Over the past 5 years, Skinvisible's EBT peaked at -$148564.0 during Q2 2021, and registered a low of -$1.5 million during Q1 2023.
  • Over the past 5 years, Skinvisible's median EBT value was -$289592.0 (recorded in 2024), while the average stood at -$356542.4.
  • Per our database at Business Quant, Skinvisible's EBT tumbled by 30964.11% in 2023 and then soared by 8084.73% in 2024.
  • Over the past 5 years, Skinvisible's EBT (Quarter) stood at -$179296.0 in 2021, then tumbled by 128.05% to -$408893.0 in 2022, then rose by 25.58% to -$304295.0 in 2023, then dropped by 20.74% to -$367406.0 in 2024, then surged by 31.89% to -$250245.0 in 2025.
  • Its EBT was -$250245.0 in Q3 2025, compared to -$278957.0 in Q2 2025 and -$281005.0 in Q1 2025.